<DOC>
	<DOCNO>NCT01880879</DOCNO>
	<brief_summary>research topic : helios After registration clinical research bidder : kinhely bio-tech Co.Ltd study design : A prospective single treatment group multicenter clinical study Number patient : Included subject 800 case Main research purpose : Evaluation safety effectiveness Mainly study finish:1 year target lesion failure Inclusion criterion : one : Gender limit age 18 80 two : myocardial ischemia angina symptom coronary artery disease three : A narrow less 50 % treat stent four : Comply instruction five : Voluntarily sign informed consent form exclusion criterion : one : Pregnant woman two : cardiac shock three : Against suppository medicine allergy four : Participated test research first 6 month five : Within 6 month PCI plan accept non cardiac surgery six : Non-compliant patient Follow-up time : A month 6 month 9 month 1 year 2 year follow-up progress plan : All center within 6 month start complete group</brief_summary>
	<brief_title>A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety Effectiveness CAD Treatment</brief_title>
	<detailed_description>desire</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Any age 18 80 sex Myocardial ischemia angina pectoris coronary artery disease An application stent diameter stenosis great 50 % Comply instruction Voluntarily sign informed consent form Pregnant woman cardiac shock Intolerance antithrombotic therapy allergy 6 month prior start study involve study Within 6 month PCI plan accept non cardiac surgery Noncompliant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>PCI</keyword>
	<keyword>stent</keyword>
</DOC>